Skyway Capital Markets is pleased to welcome Wes Chapman to its Advisory Board, a highly regarded group of experts that represent a broad spectrum of industries and who serve as advisors to the Skyway leadership team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210819005480/en/
Wes Chapman, Advisory Board Member, Skyway Capital Markets (Photo: Business Wire)
Mr. Chapman is a pioneer in the incorporation of advanced quality systems – lean/six sigma and ISO – into medical clinical practice. He is an expert in medical quality and value-based care reimbursement systems, teaching these subjects at Dartmouth and Vanderbilt. Additionally, he has extensive experience in the development of real-world evidence in medical applications and all phases of clinical trials for both drugs and devices. He also has extensive experience bringing new medical devices to market, FDA device approvals and in reimbursement for medical devices.
“We are honored to have Wes serve on our Advisory Board, and we look forward to his valuable strategic advice as we continue to grow our Healthcare practice,” remarked Skyway CEO Russ Hunt.
Mr. Chapman has an unbroken track record of strategic and operating excellence as a CEO and investor, with particular success in developing functional strategies to simultaneously grow revenues and improve profits. He has a proven ability to realize value from the companies he runs and/or invests in. He is a co-founder of Reimagine Care, an oncology service model company launched with Martin Ventures, and is a founder of Fortende Health, an advisor and broker of Medicare insurance coverage. He is, in collaboration with Dr. Kashyap Patel, President of the Community Oncology Alliance and President of Carolina Blood & Cancer Care Associates, developing a new oncology clinical trials company focused on recruitment of minority trial participants and addressing equity in the delivery of oncology care. Mr. Chapman was previously President and CEO of Verdi Oncology, a medical oncology company dedicated to value-based cancer care, which he founded in 2016.
Prior to Verdi Oncology, Mr. Chapman was an operating partner at Pharos Capital, a private equity group located in Nashville, Tennessee, with over $1.1 billion in assets under management. In addition, he served as SVP of Strategy at Tennessee Oncology, as Chairman & CEO of M2S, Inc., and as a partner at the investment banking firms of Oppenheimer & Co. and Donaldson, Lufkin & Jenrette. He has extensive international experience, running major operations for Japanese investors in North America, and extensive investment and operating experience in South America.
He is a graduate of Dartmouth College and the Tuck School of Business at Dartmouth and holds a Lean/Six Sigma Black Belt from the Thayer School of Engineering.
Along with Mr. Chapman, Skyway Capital Markets Advisory Board members include: Kenneth Cherven, retired banker and investor; Greg Freidman, CEO of Peachtree Hotel Group; Jack Murray III, Partner at Murray-Bertran; Linda Olson, President and CEO of Tampa Bay Wave; and Kiran Patel, Community Leader and Entrepreneur.
About Skyway Capital Markets, LLC
Skyway Capital Markets works with middle market companies, public and private, through customized capital services that include corporate finance, mergers & acquisitions and recapitalization. The firm differentiates itself from its competitors by providing issuers more capital market options, including access to ultra-high net worth investors, family offices, independent broker-dealers, registered investment advisors and select institutional investors. For additional information, please visit www.SkywayCapitalMarkets.com.